Analysis

Immupharma Plc (IMM) Stock Analysis

Immupharma Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to IMM.

websiteIMM/analysis/IMM

Immupharma Plc

Immupharma Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to IMM.

Stock profile

Ticker

IMM

Asset type

Stock

Market cap

$36.3M

Sector

Health Technology

Industry

Pharmaceuticals: Other

Currency

GBX

Ticker listings

Immupharma Plc may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • IMM primary listing
  • A0BMC4
  • 25I
  • IMML
  • IMM.GB

Latest Immupharma Plc news

Incanthera plc – Corporate Update & Board Changes

ImmuPharma PLC has noted an announcement from Incanthera plc regarding corporate updates and board changes, specifically that Tim McCarthy has stepped down as Executive Chairman...

ImmuPharma : FINAL RESULTS for the twelve months ended 31 December 2025

ImmuPharma : FINAL RESULTS for the twelve months ended 31 December

IMM initiatesIND-Enabling Program for Kapiglucagon

ImmuPharma PLC has initiated IND-enabling activities for its Kapiglucagon diabetes program, a proprietary glucagon prodrug for Type 1 diabetes, by engaging tranScrip Limited to ...

Holding(s) in Company

Lanstead Capital Investors LP has acquired a significant stake in Immupharma plc, now holding 17.99% of the company's voting rights. This acquisition represents a substantial in...

Chairman’s Open Letter to Shareholders

ImmuPharma PLC has successfully completed a fundraising, with shareholders approving resolutions for a £6 million Lanstead subscription and a £468,000 WRAP retail offering, sign...

Research sections

Valuation

Review valuation context for Immupharma Plc.

Future growth

Review future growth context for Immupharma Plc.

Past performance

Review past performance context for Immupharma Plc.

Financial health

Review financial health context for Immupharma Plc.

Dividend

Review dividend context for Immupharma Plc.

Management

Review management context for Immupharma Plc.

Ownership

Review ownership context for Immupharma Plc.

Other information

Review other information context for Immupharma Plc.

Community

Review community context for Immupharma Plc.